Connor Clark & Lunn Investment Management Ltd. raised its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 27.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 492,304 shares of the company’s stock after buying an additional 107,090 shares […]